🔎 Trials Near Me

Home › Soft Tissue Sarcoma › California

Soft Tissue Sarcoma clinical trials in California

39 studies for Soft Tissue Sarcoma are looking for participants at sites in California.

Cities in California

BostonGene and Exigent Genomic INsight Study

  • Stockton Hematology Oncology Medical Group, Stockton
RecruitingObservational study
Ages 18 and older · All sexes · Updated Nov 12, 2026 · NCT06272864

Study of Lurbinectedin Monotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Ewing Sarcoma

  • Children's Hospital of Los Angeles, Los Angeles
  • Lucile Packard Children's Hospital, Palo Alto
RecruitingPhase 1/2
Ages 2 to 30 · All sexes · Updated Nov 5, 2026 · NCT05734066

cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease

  • City of Hope, Duarte
RecruitingObservational studyHealthy volunteers welcome
Ages 40 and older · All sexes · Updated Nov 4, 2026 · NCT05366881

Testing Low-Dose Common Chemotherapy (Liposomal Doxorubicin) in Combination With an Anti-Cancer Drug, Peposertib, in Advanced Sarcoma

  • Los Angeles General Medical Center, Los Angeles
  • USC / Norris Comprehensive Cancer Center, Los Angeles
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Nov 4, 2026 · NCT05711615

Distance-Based Exercise to Preserve Function and Prevent Disability

  • Kaiser Permanente Dublin, Dublin
  • Kaiser Permanente-Fremont, Fremont
  • Kaiser Permanente Fresno Orchard Plaza, Fresno
  • and 10 more
Recruiting
Ages 18 and older · All sexes · Updated Nov 4, 2026 · NCT07059884

Lead-212 PSV359 Therapy for Patients With Solid Tumors

  • VA Greater Los Angeles Healthcare System, Los Angeles
  • UCLA Department of Medicine - Hematology/Oncology, Los Angeles
RecruitingPhase 1/2
Ages 18 to 90 · All sexes · Updated Oct 28, 2026 · NCT06710756

A Study of MGC026 in Participants With Advanced Solid Tumors

  • The Angeles Clinic and Research Institute, Los Angeles
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Oct 28, 2026 · NCT06242470

A Phase II Trial of Tebentafusp in HLA-A*02:01 Positive Patients With Advanced Clear Cell Sarcoma

  • University of Southern California - Norris Cancer Center, Los Angeles
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Oct 26, 2026 · NCT06942442

STC-15 as a Part of Combination Therapy With Toripalimab in Selected Advanced Cancers and as Monotherapy in Participants With Selected Sarcomas

  • University of California, San Francisco, San Francisco
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Oct 22, 2026 · NCT06975293

Fluorescence-Guided Surgical Resection for Reducing Unexpected Positive Margins in Patients With Sarcoma, SarcoSIGHT Trial

  • City of Hope Medical Center, Duarte
RecruitingPhase 2
All ages · All sexes · Updated Oct 16, 2026 · NCT07650656

A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations

  • Children's Hospital Los Angeles, Los Angeles
  • University of California at Los Angeles, Los Angeles
RecruitingPhase 1/2
Up to age 25 · All sexes · Updated Sep 25, 2026 · NCT04094610

DESTINY-PANTUMOUR04

  • Research Site, San Diego
RecruitingObservational study
Ages 18 to 130 · All sexes · Updated Sep 25, 2026 · NCT07124000

A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors

  • Kivu Trial Site, Santa Monica
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 24, 2026 · NCT07229313

Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors

  • Stanford University, Palo Alto
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Sep 8, 2026 · NCT05732831

Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas

  • Precision NextGen Oncology and Research, Beverly Hills
  • City of Hope, Duarte
  • Valkyrie Clinical Trials, Los Angeles
  • and 3 more
RecruitingPhase 1
Ages 12 to 85 · All sexes · Updated Sep 8, 2026 · NCT03715933

Cabozantinib With Ifosfamide in Relapsed/Refractory Sarcomas

  • University of California San Francisco, San Francisco
RecruitingPhase 1
Ages 5 to 40 · All sexes · Updated Sep 3, 2026 · NCT06156410

A Study to Investigate Efficacy & Safety of Intratumoral INT230-6 Compared to US Standard of Care in Adults With Soft Tissue Sarcomas (INVINCIBLE-3)

  • USC/Norris Comprehensive Cancer Center, Los Angeles
  • Sarcoma Oncology Center, Santa Monica
  • University of California Los Angeles (UCLA) - Santa Monica Cancer Care, Santa Monica
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Aug 11, 2026 · NCT06263231

Feasibility Study on the Effect of a Methionine-Reduced Diet on Serum Levels in Pts w/ Solid Tumors

  • Chao Family Comprehensive Cancer Center, University of California, Irvine, Orange
RecruitingEarly phase 1
Ages 18 and older · All sexes · Updated Jul 31, 2026 · NCT07628634

Phase 1a/b Study of ZL-6201 Safety, PK, and Preliminary Efficacy in Sarcoma and Selected Tumors

  • Zai Lab Site 02003, Los Angeles
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Jul 23, 2026 · NCT07374848

Trial of Single Protein Encapsulated Doxorubicin, SPEDOX-6 in Advanced Malignancies

  • Chao Family Comprehensive Cancer Center University of California, Irvine, Orange
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Jul 17, 2026 · NCT07064018

Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial

  • Chao Family Comprehensive Cancer Center, University of California Irvine, Orange
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Jul 14, 2026 · NCT06580002

Locally ablatiVe therApy in oLigO-pRogressive sOlid tUmorS (VALOROUS)

  • University of California, Davis, Sacramento
Recruiting
Ages 18 and older · All sexes · Updated Jul 8, 2026 · NCT06103669

Navigation Intervention for Adolescent and Young Adult Cancer Survivors

  • KP Southern California - Department of Research & Evaluation, Pasadena
Recruiting
Ages 21 to 45 · All sexes · Updated Jul 6, 2026 · NCT07406087

A Phase 1, First-in-human Study of OKN4395 and Pembrolizumab in Patients With Solid Tumors

  • Precision NextGen Oncology and Research Center, Beverly Hills
  • Sarcoma Oncology Center, Santa Monica
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Jun 11, 2026 · NCT06789172

5-Day Preoperative Radiation for Soft Tissue Sarcoma

  • Stanford University, Palo Alto
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Jun 10, 2026 · NCT06087861

A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements

  • St Joseph Heritage Healthcare, Santa Rosa
RecruitingPhase 1/2
Ages 12 and older · All sexes · Updated May 27, 2026 · NCT03093116

Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma

  • Lucille Packard Children's Hospital Stanford, Palo Alto
RecruitingPhase 1/2
12 Months – 30 Years · All sexes · Updated May 19, 2026 · NCT04901702

Autologous B7-H3 Chimeric Antigen Receptor T Cells in Relapsed/Refractory Solid Tumors

  • Stanford University, Palo Alto
RecruitingPhase 1
Ages 2 to 30 · All sexes · Updated May 7, 2026 · NCT06500819

Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer

  • Beckman Research Institute of City of Hope, Duarte
  • VA Medical Center, Fresno, Fresno
  • Santa Clara Valley Medical Center, Fruitdale
  • and 5 more
Recruiting
Ages 18 and older · All sexes · Updated Apr 30, 2026 · NCT05297734

Phase II Study of 5-Day Hypofractionated Preoperative Radiation Therapy for Soft Tissue Sarcomas: Expansion Cohort

  • UCLA / Jonsson Comprehensive Cancer Center, Los Angeles
Recruiting
Ages 18 and older · All sexes · Updated Mar 10, 2026 · NCT02701153

Phase II Trial of Lung Chemoemobolization

  • City of Hope Medical Center, Duarte
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Mar 5, 2026 · NCT05672108

Riluzole For Preventing Cognitive Dysfunction in Ca Pts Receiving Chemo (REFOCUS): Pilot Trial

  • Chao Family Comprehensive Cancer Center, University of California Irvine, Orange
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Mar 3, 2026 · NCT07447050

Phase III Trial of Anlotinib, Catequentinib in Advanced Alveolar Soft Part Sarcoma, Leiomyosarcoma, Synovial Sarcoma (APROMISS)

  • Sarcoma Oncology Center, Santa Monica
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Feb 25, 2026 · NCT03016819

A Study of MT-4561 in Patients With Various Advanced Solid Tumors

  • University of Southern California, Los Angeles
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Dec 11, 2025 · NCT06943521

64Cu-LNTH-1363S in Patients With Sarcoma or Gastrointestinal Tract Cancer

  • City of Hope, Duarte
  • UC Irvine Health - Chao Family Comprehensive Cancer Center, Orange
  • Stanford Hospital & Clinics, Stanford
RecruitingPhase 1/2
Ages 15 and older · All sexes · Updated Aug 12, 2025 · NCT06298916

Talimogene Laherparepvec, Nivolumab and Trabectedin for Sarcoma

  • Sarcoma Oncology Center, Santa Monica
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Feb 24, 2025 · NCT03886311

SAINT:Trabectedin, Ipilimumab and Nivolumab for Previously Treated Advanced Soft Tissue Sarcoma

  • Sarcoma Oncology Research Center, Santa Monica
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Feb 24, 2025 · NCT03138161

REtroperitoneal SArcoma Registry: an International Prospective Initiative

  • University of Southern California (USC), Los Angeles
RecruitingObservational study
Ages 18 and older · All sexes · Updated Feb 12, 2019 · NCT03838718

From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.